The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry
Kane, J, Honigfeld, G, Singer, J, Meltzer, H.
Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry
1988; 45: 789–96.
Pirmohamed, M, Park, K.
Mechanism of clozapine-induced agranulocytosis. CNS Drugs
1997; 7: 139–158.
Gerson, SL. Clozapine – deciphering the risks. N Engl J Med
1993; 329: 204–5.
Gerson, SL. G-CSF and the management of clozapine-induced agranulocytosis. J Clin Psychiatry
1994; 55: 139–42.
Atkin, K, Kendall, F, Gould, D, Freeman, H, Lieberman, J, O'Sullivan, D.
Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry
1996; 169: 483–8.
Dunk, LR, Annan, LJ, Andrews, CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry
2006; 188: 255–63.
Munro, J, O'Sullivan, D, Andrews, C, Arana, A, Mortimer, A, Kerwin, R.
Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry
1999; 175: 576–80.
Kelly, DL, Kreyenbuhl, J, Dixon, L, Love, RC, Medoff, D, Conley, RR. Clozapine underutilization and discontinuation in African Americans due to leucopenia. Schizophr Bull
2007; 33: 1221–4.
Williams, DP, Pirmohamed, M, Naisbitt, DJ, Maggs, JL, Park, BK. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J Pharmacol Exp Ther
1997; 283: 1375–82.
Sackett, DL, Rosenberg, WM, Gray, JA, Haynes, RB, Richardson, WS. Evidence based medicine: what it is and what it isn't. BMJ
1996; 312: 71–2.
Esposito, D, Hardy, P, Corruble, E.
Clozapine treatment following blood dyscrasia. Br J Psychiatry
2006; 189: 186.
Ghaznavi, S, Nakic, M, Rao, P, Hu, J, Brewer, JA, Hannestad, J, Bhagwagar, Z.
Rechallenge with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry
2008; 165: 813–8.
Taylor, D, Paton, C, Kapur, S.
The South London and Maudsley NHS Foundation Trust and Oxleas NHS Foundation Trust Prescribing Guidelines (10th edn). Informa Healthcare, 2009.
Whiskey, E, Taylor, D.
Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs
2007; 21: 25–35.
Dernovsek, Z, Tavcar, R.
Risperidone induced leucopenia and neutropenia. Br J Psychiatry
1997; 171: 393–4.
Thangadurai, P, Jyothi, KS, Gopalakrishnan, R, Kuruvilla, A, Jacob, KS. Reversible neutropenia with olanzapine following clozapine-induced neutropenia. Am J Psychiatry
2006; 163: 1298.